| 0.842 | 0.001 | 0.842 | Sphingosine 1-phosphate receptor agonist | | |
| 0.811 | 0.001 | 0.811 | Sphingosine 1-phosphate receptor 1 agonist | | |
| 0.601 | 0.027 | 0.601 | Cyclophilin D inhibitor | | |
| 0.575 | 0.016 | 0.575 | Immunosuppressant | | |
| 0.544 | 0.014 | 0.544 | Calcium channel L-type activator | | |
| 0.462 | 0.003 | 0.462 | Sphingosine 1-phosphate receptor antagonist | | |
| 0.408 | 0.002 | 0.408 | Sphingosine 1-phosphate receptor 4 agonist | | |
| 0.376 | 0.003 | 0.376 | Sphingosine 1-phosphate receptor 5 agonist | | |
| 0.392 | 0.023 | 0.392 | Anticonvulsant | | |
| 0.425 | 0.057 | 0.425 | Antiobesity | | |
| 0.384 | 0.028 | 0.384 | Hypolipemic | | |
| 0.335 | 0.002 | 0.335 | Sphingosine 1-phosphate receptor 3 agonist | | |
| 0.397 | 0.086 | 0.397 | Analgesic | | |
| 0.418 | 0.128 | 0.418 | Antiinflammatory | | |
| 0.269 | 0.002 | 0.269 | Sphingosine 1-phosphate receptor 3 antagonist | | |
| 0.204 | 0.01 | 0.204 | Sphingosine 1-phosphate receptor 5 antagonist | | |
| 0.259 | 0.072 | 0.259 | Hypoglycemic | | |
| 0.181 | 0.005 | 0.181 | Peroxisome proliferator-activated receptor alpha agonist | | |
| 0.221 | 0.054 | 0.221 | Insulin sensitizer | | |
| 0.163 | 0.004 | 0.163 | Sphingosine 1-phosphate receptor 1 antagonist | | |
| 0.163 | 0.01 | 0.163 | Peroxisome proliferator-activated receptor gamma agonist | | |
| 0.173 | 0.039 | 0.173 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | | |
| 0.164 | 0.039 | 0.164 | Farnesoid X receptor antagonist | | |
| 0.082 | 0.005 | 0.082 | GABA uptake inhibitor | | |
| 0.13 | 0.056 | 0.13 | Sphingosine 1-phosphate receptor 4 antagonist | | |
| 0.125 | 0.051 | 0.125 | Calcium channel (voltage-sensitive) blocker | | |
| 0.074 | 0.008 | 0.074 | Peroxisome proliferator-activated receptor delta agonist | | |
| 0.089 | 0.031 | 0.089 | Calcium channel L-type blocker | | |
| 0.241 | 0.185 | 0.241 | Antibacterial | | |
| 0.094 | 0.049 | 0.094 | Acetylcholine M3 receptor agonist | | |
| 0.051 | 0.017 | 0.051 | G protein-coupled receptor agonist | | |
| 0.044 | 0.012 | 0.044 | Glutamate (mGluR8) antagonist | | |
| 0.214 | 0.184 | 0.214 | Toll-Like receptor 7 agonist | | |
| 0.04 | 0.023 | 0.04 | Farnesoid X receptor agonist | | |
| 0.113 | 0.096 | 0.113 | Calcium channel blocker | | |
| 0.022 | 0.006 | 0.022 | CXC chemokine 5 receptor antagonist | | |
| 0.205 | 0.196 | 0.205 | Toll-Like receptor agonist | | |
| 0.051 | 0.042 | 0.051 | Acetylcholine muscarinic agonist | | |
| 0.031 | 0.028 | 0.031 | Glutamate (mGluR group II) agonist | | |